Misty Shuo Zhang

1.0k total citations · 1 hit paper
13 papers, 681 citations indexed

About

Misty Shuo Zhang is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Misty Shuo Zhang has authored 13 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Cancer Research and 3 papers in Immunology. Recurrent topics in Misty Shuo Zhang's work include Cancer, Hypoxia, and Metabolism (7 papers), RNA modifications and cancer (5 papers) and interferon and immune responses (2 papers). Misty Shuo Zhang is often cited by papers focused on Cancer, Hypoxia, and Metabolism (7 papers), RNA modifications and cancer (5 papers) and interferon and immune responses (2 papers). Misty Shuo Zhang collaborates with scholars based in Hong Kong, China and Canada. Misty Shuo Zhang's co-authors include Carmen Chak‐Lui Wong, Irene Oi‐Lin Ng, Chun‐Ming Wong, Derek Lee, Cheuk‐Ting Law, Felice Ho‐Ching Tsang, Lai Wei, Allen Zhang, Don Wai‐Ching Chin and Jialing Shen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Hepatology.

In The Last Decade

Misty Shuo Zhang

13 papers receiving 675 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC

2019 297 citations Lai Wei, Derek Lee et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Misty Shuo Zhang Hong Kong	10	467	283	167	147	72	13	681
Samuel J. Vidal United States	7	473 1.0×	217 0.8×	164 1.0×	308 2.1×	73 1.0×	12	798
Cerise Yuen‐Ki Chan Hong Kong	10	403 0.9×	232 0.8×	162 1.0×	103 0.7×	66 0.9×	12	576
Lantian Tian China	11	301 0.6×	218 0.8×	85 0.5×	128 0.9×	43 0.6×	21	549
Zhibin Liao China	21	794 1.7×	468 1.7×	100 0.6×	181 1.2×	85 1.2×	47	1.0k
Lehang Lin China	14	627 1.3×	377 1.3×	128 0.8×	165 1.1×	157 2.2×	18	855
Carla Kurkjian United States	17	481 1.0×	130 0.5×	157 0.9×	302 2.1×	60 0.8×	41	830
Yibin Ren China	12	365 0.8×	163 0.6×	46 0.3×	149 1.0×	85 1.2×	13	531
Romain Donné France	6	267 0.6×	147 0.5×	122 0.7×	127 0.9×	116 1.6×	8	598
Ayano Kabashima Japan	11	394 0.8×	160 0.6×	43 0.3×	211 1.4×	107 1.5×	16	625
Wubin Zheng China	9	325 0.7×	262 0.9×	134 0.8×	193 1.3×	165 2.3×	12	618

Countries citing papers authored by Misty Shuo Zhang

Since Specialization

Citations

This map shows the geographic impact of Misty Shuo Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Misty Shuo Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Misty Shuo Zhang more than expected).

Fields of papers citing papers by Misty Shuo Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Misty Shuo Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Misty Shuo Zhang. The network helps show where Misty Shuo Zhang may publish in the future.

Co-authorship network of co-authors of Misty Shuo Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Misty Shuo Zhang. A scholar is included among the top collaborators of Misty Shuo Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Misty Shuo Zhang. Misty Shuo Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Chen, Yi‐Ling, Derek Lee, Mengjie Wu, et al.. (2025). Mevalonate pathway promotes liver cancer by suppressing ferroptosis through CoQ10 production and selenocysteine-tRNA modification. Journal of Hepatology. 83(6). 1338–1352. 3 indexed citations

Wong, Po Yee, et al.. (2024). Cell cycle inhibitors activate the hypoxia-induced DDX41/STING pathway to mediate antitumor immune response in liver cancer. JCI Insight. 9(22). 5 indexed citations

Cheu, Jacinth Wing‐Sum, Derek Lee, Qidong Li, et al.. (2023). Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver Cancer. Cellular and Molecular Gastroenterology and Hepatology. 16(1). 133–159. 80 indexed citations

Chan, Cerise Yuen‐Ki, David Kung‐Chun Chiu, Vincent Wai‐Hin Yuen, et al.. (2022). CFI-402257, a TTK inhibitor, effectively suppresses hepatocellular carcinoma. Proceedings of the National Academy of Sciences. 119(32). e2119514119–e2119514119. 38 indexed citations

Yuen, Vincent Wai‐Hin, David Kung‐Chun Chiu, Cheuk‐Ting Law, et al.. (2022). Using mouse liver cancer models based on somatic genome editing to predict immune checkpoint inhibitor responses. Journal of Hepatology. 78(2). 376–389. 42 indexed citations

Shen, Jialing, Chunxue Yang, Misty Shuo Zhang, et al.. (2022). Histone chaperone FACT complex coordinates with HIF to mediate an expeditious transcription program to adapt to poorly oxygenated cancers. Cell Reports. 38(5). 110304–110304. 11 indexed citations

Zhang, Misty Shuo, Vincent Wai‐Hin Yuen, David Kung‐Chun Chiu, et al.. (2022). Hypoxia-induced macropinocytosis represents a metabolic route for liver cancer. Nature Communications. 13(1). 954–954. 77 indexed citations

Yang, Chunxue, Derek Lee, Misty Shuo Zhang, et al.. (2022). Genome‐Wide CRISPR/Cas9 Library Screening Revealed Dietary Restriction of Glutamine in Combination with Inhibition of Pyruvate Metabolism as Effective Liver Cancer Treatment. Advanced Science. 9(34). e2202104–e2202104. 23 indexed citations

Bao, Macus Hao‐Ran, Chunxue Yang, Aki Pui‐Wah Tse, et al.. (2021). Genome-wide CRISPR-Cas9 knockout library screening identified PTPMT1 in cardiolipin synthesis is crucial to survival in hypoxia in liver cancer. Cell Reports. 34(4). 108676–108676. 44 indexed citations

10.

Lee, Derek, Misty Shuo Zhang, Felice Ho‐Ching Tsang, et al.. (2021). Adaptive and Constitutive Activations of Malic Enzymes Confer Liver Cancer Multilayered Protection Against Reactive Oxygen Species. Hepatology. 74(2). 776–796. 19 indexed citations

11.

Chiu, David Kung‐Chun, Misty Shuo Zhang, Aki Pui‐Wah Tse, & Carmen Chak‐Lui Wong. (2019). Assessment of Stabilization and Activity of the HIFs Important for Hypoxia-Induced Signalling in Cancer Cells. Methods in molecular biology. 1928. 77–99. 7 indexed citations

12.

Wei, Lai, Derek Lee, Cheuk‐Ting Law, et al.. (2019). Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC. Nature Communications. 10(1). 4681–4681. 297 indexed citations breakdown →

13.

Tsang, Felice Ho‐Ching, David Kung‐Chun Chiu, Misty Shuo Zhang, et al.. (2018). Hepatitis transactivator protein X promotes extracellular matrix modification through HIF/LOX pathway in liver cancer. Oncogenesis. 7(5). 44–44. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact